DK1723135T3
(en )
2013-09-02
KNOWN HYDROXY-6-HETEROARYLPHENANTHRIDINES AND THEIR USE AS PDE4 INHIBITORS
DK1723128T3
(en )
2013-02-18
Heteroarlurines and their use as glucokinase activators
DK2439205T3
(en )
2015-06-22
Carboxamide compounds and their use as calpain inhibitors
DK1586319T3
(en )
2010-02-08
Thiadiazolidinones as GSK-3 inhibitors
DK1789041T3
(en )
2008-09-08
Aryl-pyridine derivatives as 11-beta-HSD1 inhibitors
DK1797042T3
(en )
2009-03-02
Indozolone derivatives as 11B-HSD1 inhibitors
NO20161397A1
(en )
2016-09-02
Non-nucleoside-based reverse transcriptase inhibitors
DK1954140T3
(en )
2013-06-17
GLYCEROLLEVULINETKETALS AND THEIR USE
DK1841757T3
(en )
2010-09-13
Heteroaromatic quinoline compounds and their use as PDE10 inhibitors
DK2099447T3
(en )
2013-02-18
IMIDAZOTRIAZINES AND IMIDAZOPYRIMIDINES AS KINASE INHIBITORS
DK1888595T3
(en )
2012-05-29
Spiro-oxindole compounds and their applications as therapeutic agents
DK1720866T3
(en )
2011-11-21
Course of action
DK1704145T3
(en )
2012-09-24
Selective kinase inhibitors
DK1928840T3
(en )
2011-09-12
1H-pyrazole-4-carboxamides, their preparation and their use as 11-beta-hydroxysteroid dehydrogenase inhibitors
DK1581532T3
(en )
2010-08-16
Pyrazolo-3,4-B pyridine compounds and their use as phosphodiesterase inhibitors
DK2049557T3
(en )
2011-06-14
1 - (- D-glycopyranosyl) -3- (4-cyclopropylphenylmethyl) -4-haloindole derivatives and their use as sglt inhibitors
DK1765327T3
(en )
2014-11-03
Compounds, Compositions and Methods
DK1959951T3
(en )
2010-03-01
Heteroberl-substituted piperidine derivatives as L-CPT1 inhibitors
DE602005005527D1
(en )
2008-05-08
shut-off
DK1725553T3
(en )
2008-08-18
Tetrahydropyridoindole derivatives
ATE383361T1
(en )
2008-01-15
PYRRAZOLOPYRIMIDE DERIVATIVES
ATE540935T1
(en )
2012-01-15
CHINAZOLINE DERIVATIVES
DK1763517T3
(en )
2011-06-06
Pyrimidine derivatives as 11beta-HSD1 inhibitors
ATE417830T1
(en )
2009-01-15
SULFONYLBENZIMIDAZOLE DERIVATIVES
DK2067854T3
(en )
2015-01-26
cloning